pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
pharmadog news

Browse

3,812 stories matching this filter · ← front page

★ save view↓export CSV
rangeto
sort
recentoldestsourcealpha
source
STAT1784Endpoints1390Fierce Biotech710BioSpace700BioPharma Dive525raps234onclive165fda recalls113fda medwatch
therapy area
allOncology12325Rare Disease3219Immunology2863Cardiology2745Hematology2177Pulmonology2143Vaccines
  • CDC-funded hepatitis B vaccine trial in Guinea-Bissau paused amid ethical concerns
    The U.S. Centers for Disease Control and Prevention awarded a $1.6 million grant to a Danish research group to compare hepatitis B vaccination at birth versus at six weeks in infants from Guinea‑Bi…
    STAT · 6mo agoRegulatoryNegative↗ source
  • Utah doctors urge state to suspend Doctronic AI prescription-refill program
    Utah medical licensing board members have asked the state to halt a temporary program that lets startup Doctronic use artificial intelligence to refill prescriptions. The board says the AI-driven…
    Endpoints · 6mo agoRegulatoryNegative↗ source
← prev
page 151 of 153
next →
111
globenewswire health73
fda press59
1796
Psychiatry & CNS1204
Ophthalmology1060
Pain777
Endocrinology & Metabolism776
Nephrology760
  • NIH-funded studies often omit sex-specific results, study finds
    A new analysis of NIH-funded papers reveals that less than half report outcomes separately for men and women. Researchers examined 574 articles published between 2017 and 2024; while 61% included…
    STAT · 6mo agoRegulatoryNegative↗ source
  • Experts say Covid risk has faded, but boosters still advised for vulnerable groups
    Health journalist Helen Branswell reflects on how Covid-19, once the dominant global threat, has receded in public consciousness. Six years after the 2020 lockdowns, mask-wearing and social distanc…
    STAT · 6mo agoNeutral↗ source
  • Mental health clinicians face contracts that charge patients for staying with them
    Sarah Cady, a psychiatric nurse practitioner near New York City, discovered a clause in an employment contract that would require her to pay $7,500 for each patient who chose to continue treatment…
    STAT · 6mo agoNegative↗ source
  • Democrats criticize Health Secretary Kennedy for not releasing vaccine contract
    Senators asked HHS Secretary Robert F. Kennedy Jr. to release a contract with a longtime vaccine critic by a Friday deadline. Kennedy initially said he would be happy to share it, but the deadline…
    STAT · 6mo agoRegulatoryNegative↗ source
  • UK biotech funding shows early recovery after mid-2025 lull, BIA reports
    The BioIndustry Association released data indicating that equity financing for UK biotech companies is beginning to rise again in early 2026. The trend follows a slowdown that began in mid-2025, w…
    Endpoints · 6mo agoPositive↗ source
  • Integrative medicine doctor Kristine Blanche, wife of acting U.S. attorney general, joins NIH's complementary health advisory council
    Kristine Blanche, an integrative medicine physician and spouse of acting U.S. attorney general Todd Blanche, has been appointed to an NIH advisory council. She will serve on the advisory council f…
    STAT · 6mo agoNeutral↗ source
  • CDC flu research pioneer Nancy Cox dies at 77
    Nancy Cox, a longtime CDC veteran, passed away at age 77 after battling glioblastoma, a form of brain cancer. Cox led the agency's influenza division for 22 years, expanding the team from a modest…
    STAT · 6mo agoNeutral↗ source
  • New Podcast 'Drug Story' Explores the Cultural Impact of Blockbuster Medications
    The First Opinion team has launched a new podcast called “Drug Story,” hosted by journalist and entrepreneur Thomas Goetz. The series aims to uncover the hidden narratives behind widely used medici…
    STAT · 6mo agoPositive↗ source
  • Endpoints Weekly celebrates Neal Awards while previewing Sanofi, Lilly and RevMed updates
    Endpoints Weekly released its latest edition on April 25, 2026, noting a celebratory tone after the publication earned three Neal Awards for B2B journalism excellence. The issue highlights several…
    Endpoints · 6mo agoPositive↗ source
  • Eli Lilly to acquire cancer cell therapy startup Kelonia Therapeutics for $3.2 billion
    Eli Lilly announced it will buy privately held Kelonia Therapeutics, a biotech focused on cell therapies for cancer and autoimmune diseases, in a deal valued at $3.2 billion. Kelonia has operated…
    STAT · 6mo agoDealPositive↗ source
  • European regulators recommend Sanofi's MS drug tolebrutinib for approval after US rejection
    European Medicines Agency officials issued a positive recommendation for tolebrutinib, an experimental multiple sclerosis therapy from Sanofi, after the U.S. FDA rejected the drug earlier this year…
    BioPharma Dive · 6mo agoRegulatoryPositive↗ source
  • Sanofi’s tolebrutinib receives EU CHMP endorsement for specific multiple sclerosis patients despite US FDA setback
    Sanofi's BTK inhibitor tolebrutinib is moving toward approval in the European Union for a subset of multiple sclerosis patients. The Committee for Medicinal Products for Human Use (CHMP) of the Eu…
    Endpoints · 6mo agoRegulatoryPositive↗ source
  • FDA to fast-track review of three psychedelic therapies for depression and PTSD
    The FDA announced it will accelerate the review of psychedelic drugs from three companies as part of a broader initiative to increase access to mental-health treatments. Compass Pathways will rece…
    STAT · 6mo agoRegulatoryPositive↗ source
  • Utah medical board urges halt to AI-driven prescription renewal pilot
    Utah launched a pilot program that partners with AI startup Doctronic to let a chatbot conduct clinical evaluations and automatically renew prescriptions for roughly 200 medications, without direct…
    STAT · 6mo agoRegulatoryNegative↗ source
  • Avalyn Pharma targets $182M IPO as WHO prequalifies Novartis malaria drug
    Avalyn Pharma announced plans for an initial public offering that could raise about $182 million in net proceeds. The company is developing inhaled formulations of drugs already approved for pulmon…
    Endpoints · 6mo agoDealNeutral↗ source
  • Novartis withdraws EU filing for Pluvicto label expansion into early-stage prostate cancer
    Novartis announced it has pulled its application to the European Medicines Agency to extend the label of its radioligand therapy Pluvicto for use in earlier stages of prostate cancer. The move com…
    Endpoints · 6mo agoRegulatoryNegative↗ source
  • Lilly shares slide as Foundayo prescriptions lag expectations, while Novo's Wegovy gains momentum
    Eli Lilly's stock fell nearly 5% after the latest weekly prescription count for its obesity drug Foundayo missed analysts' expectations. IQVIA data showed U.S. prescriptions for Foundayo reached 3…
    BioPharma Dive · 6mo agoNegative readoutNegative↗ source
  • Trump announces drug pricing deal with Regeneron, completing White House's 17-deal target
    President Trump announced a drug‑pricing agreement with Regeneron Pharmaceuticals, marking the final deal in the administration's goal of securing 17 pricing arrangements. The agreement is intende…
    STAT · 6mo agoDealPositive↗ source
  • Sanofi's multiple sclerosis drug, previously rejected by FDA, receives positive recommendation from European regulators
    Sanofi's multiple sclerosis drug, which the U.S. FDA turned down late last year, has now been reviewed by European authorities. The European regulators issued a positive recommendation today, sugg…
    STAT · 6mo agoRegulatoryPositive↗ source
  • White House signs executive order to expand access to psychedelic therapies
    President Trump signed an executive order aimed at increasing the availability of psychedelic drug treatments. The order was announced alongside podcaster Joe Rogan, who said he had messaged the pr…
    STAT · 6mo agoRegulatoryPositive↗ source
  • FDA grants fast-track vouchers to three psychedelic firms
    The FDA announced it has issued fast-track development vouchers to three companies working on psychedelic therapies. The recipients are R&DCompass, Transcend, and the Usona Institute. The vouchers…
    Endpoints · 6mo agoRegulatoryPositive↗ source
  • UC Berkeley spinout explores gene-editing approach to GLP-1 based weight-loss therapy
    UC Berkeley researchers have launched a startup that plans to use jumping genes to deliver GLP-1 gene therapy for obesity treatment. The approach seeks to create a long-lasting source of the hormon…
    Endpoints · 6mo agoNeutral↗ source
  • Guest-edited journal issues face mass retractions over compromised peer review
    A recent retraction by the British Medical Journal’s publishing group removed almost an entire special issue of the Journal of Medical Genetics that focused on cancer immunotherapies. The journal…
    STAT · 6mo agoNegative↗ source